Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sharif

Showing results (11-20 of 423) with videos related to

Pageof 43
Sort By:
Current Opinion in Pharmacology|January 3, 2024
Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drugNajam A Sharif
Dolentium Hominum|March 8, 2002
The economy and health in the light of Islamic principlesK A Sharif
Neurochemical Research|October 1, 1990
A novel substance P binding site in rat brain regions modulates TRH receptor bindingN A Sharif
ACS Pharmacology & Translational Science|December 21, 2020
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810Najam A Sharif
Biofactors (Oxford, England)|May 20, 2022
PAF-induced inflammatory and immuno-allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effectsNajam A Sharif
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene TherapiesNajam A Sharif
Journal of Neurochemistry|February 1, 1988
Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systemsN A Sharif
The Journal of Clinical Psychiatry|December 10, 1998
Common treatment goals of antipsychotics: acute treatmentZ A Sharif
International Review of Neurobiology|January 1, 1985
Multiple synaptic receptors for neuroactive amino acid transmitters--new vistasN A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 20, 2015
Novel potential treatment modalities for ocular hypertension: focus on angiotensin and bradykinin system axesNajam A Sharif
Pageof 43

Showing results (11-20 of 423) with videos related to

Sort By:
Pageof 43
Current Opinion in Pharmacology|January 3, 2024
Human experience and efficacy of omidenepag isopropyl (Eybelis®; Omlonti®): Discovery to approval of the novel non-prostaglandin EP2-receptor-selective agonist ocular hypotensive drugNajam A Sharif
Dolentium Hominum|March 8, 2002
The economy and health in the light of Islamic principlesK A Sharif
Neurochemical Research|October 1, 1990
A novel substance P binding site in rat brain regions modulates TRH receptor bindingN A Sharif
ACS Pharmacology & Translational Science|December 21, 2020
Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810Najam A Sharif
Biofactors (Oxford, England)|May 20, 2022
PAF-induced inflammatory and immuno-allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effectsNajam A Sharif
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene TherapiesNajam A Sharif
Journal of Neurochemistry|February 1, 1988
Chemical and surgical lesions of rat olfactory bulb: changes in thyrotropin-releasing hormone and other systemsN A Sharif
The Journal of Clinical Psychiatry|December 10, 1998
Common treatment goals of antipsychotics: acute treatmentZ A Sharif
International Review of Neurobiology|January 1, 1985
Multiple synaptic receptors for neuroactive amino acid transmitters--new vistasN A Sharif
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|January 20, 2015
Novel potential treatment modalities for ocular hypertension: focus on angiotensin and bradykinin system axesNajam A Sharif
Pageof 43